Oligometastatic prostate cancer
Conditions
Interventions
Metastasis-directed therapy group:None
Sponsors
The First Affiliated Hospital of Naval Medical University
Eligibility
Sex/Gender
Male
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. The patient was histologically confirmed to have prostate cancer in the initial phase of treatment. 2. At least one and up to five active metastatic lesions were detected through PSMA PET-CT or mpMRI. 3. Following the diagnosis of oligometastatic prostate cancer, the patient received systemic therapy or a combination of systemic therapy and targeted treatment of the metastatic lesions.
Exclusion criteria
Exclusion criteria: 1. The patient was found to have oligometastases through conventional imaging modalities (whole-body bone scan, CT). 2. Accompanied by visceral metastases. 3. Patients with severe data deficiency. 4. Patients who received palliative radiotherapy, which did not encompass all active metastatic lesions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression-free survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Next-line systemic treatment-free survival;Polymetastasis-free survival;Radiotherapy toxicities;Biochemical reaction rate;Local control rate; | — |
Countries
China
Contacts
Public ContactXu Gao
The First Affiliated Hospital of Naval Medical University
Outcome results
None listed